CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc.

NASDAQ:CASI

Overview | Financials
Company Name CASI Pharmaceuticals, Inc.
Symbol CASI
Currency USD
Price 6.5
Market Cap 87,109,100
Dividend Yield 0%
52-week-range 1.9 - 8.48
Industry Biotechnology
Sector Healthcare
CEO Dr. Wei-Wu He Ph.D.
Website https://www.casipharmaceuticals.com

An error occurred while fetching data.

About CASI Pharmaceuticals, Inc.

CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The

Related Stocks

BioVie Inc. logo

BioVie Inc.

BIVI

2.49 USD

Lantern Pharma Inc. logo

Lantern Pharma Inc.

LTRN

3.42 USD

SELLAS Life Sciences Group, Inc. logo

SELLAS Life Sciences Group, Inc.

SLS

1.19 USD

Achieve Life Sciences, Inc. logo

Achieve Life Sciences, Inc.

ACHV

4.165 USD

Dyadic International, Inc. logo

Dyadic International, Inc.

DYAI

1.26 USD

Great Elm Group, Inc. logo

Great Elm Group, Inc.

GEG

1.87 USD

Silver Spike Investment Corp. logo

Silver Spike Investment Corp.

SSIC

11.46 USD

Financials

Numbers are in millions USD

Numbers are in millions USD